The efficacy of a new high-intensity focused ultrasound therapy for metastatic pancreatic cancer

References

• Chen W, Zheng R, Zuo T, et al. National cancer incidence and mortality in China, 2012. Chin J Cancer Res. 2016;28(1):1–11.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.
   PubMed Web of Science ®Google Scholar
• Burris HA, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 1997;15(6):2403–2413.
   PubMed Web of Science ®Google Scholar
• Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364(19):1817–1825.
   PubMed Web of Science ®Google Scholar
• Von Hoff DD, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369(18):1691–1703.
   PubMed Web of Science ®Google Scholar
• Iacobuzio-Donahue CA, Fu B, Yachida S, et al. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol. 2009;27(11):1806–1813.
   PubMed Web of Science ®Google Scholar
• Heestand GM, Murphy JD, Lowy AM. Approach to patients with pancreatic cancer without detectable metastases. J Clin Oncol. 2015;33(16):1770–1778.
   PubMed Web of Science ®Google Scholar
• Loehrer PJ, Sr., Feng Y, Cardenes H, et al. Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial. J Clin Oncol. 2011;29(31):4105–4112.
   PubMed Web of Science ®Google Scholar
• Chauffert B, Mornex F, Bonnetain F, et al. Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study. Ann Oncol. 2008;19(9):1592–1599.
   PubMed Web of Science ®Google Scholar
• Ierardi AM, Lucchina N, Bacuzzi A, et al. Percutaneous ablation therapies of inoperable pancreatic cancer: a systematic review. Ann Gastroenterol. 2015;28(4):431–439.
   PubMed Web of Science ®Google Scholar
• Petrou A, Moris D, Paul Tabet P, et al. Ablation of the locally advanced pancreatic cancer: An introduction and brief summary of techniques. J Buon. 2016;21(3):650–658.
   PubMed Web of Science ®Google Scholar
• Lygidakis NJ, Sharma SK, Papastratis P, et al. Microwave ablation in locally advanced pancreatic carcinoma–a new look. Hepatogastroenterology. 2007;54(77):1305–1310.
   PubMedGoogle Scholar
• Girelli R, Frigerio I, Giardino A, et al. Results of 100 pancreatic radiofrequency ablations in the context of a multimodal strategy for stage III ductal adenocarcinoma. Langenbecks Arch Surg. 2013;398(1):63–69.
   PubMed Web of Science ®Google Scholar
• Ierardi AM, Biondetti P, Coppola A, et al. Percutaneous microwave thermosphere ablation of pancreatic tumours. Gland Surg. 2018;7(2):59–66.
   PubMed Web of Science ®Google Scholar
• Ierardi AM, Lucchina N, Petrillo M, et al. Systematic review of minimally invasive ablation treatment for locally advanced pancreatic cancer. Radiol Med. 2014;119(7):483–498.
   PubMed Web of Science ®Google Scholar
• Rombouts SJ, Vogel JA, van Santvoort HC, et al. Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer. Br J Surg. 2015;102(3):182–193.
   PubMed Web of Science ®Google Scholar
• Orsi F, Arnone P, Chen W, et al. High intensity focused ultrasound ablation: a new therapeutic option for solid tumors. J Cancer Res Ther. 2010;6(4):414–420.
   PubMed Web of Science ®Google Scholar
• Zhou Y. High-intensity focused ultrasound treatment for advanced pancreatic cancer. Gastroenterol Res Pract. 2014;2014:205325
   PubMed Web of Science ®Google Scholar
• Xiaoping L, Leizhen Z. Advances of high intensity focused ultrasound (HIFU) for pancreatic cancer. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology. Int J Hyperthermia. 2013;29(7):678–682.
   PubMed Web of Science ®Google Scholar
• Marinova M, Rauch M, Mücke M, et al. High-intensity focused ultrasound (HIFU) for pancreatic carcinoma: evaluation of feasibility, reduction of tumour volume and pain intensity. Eur Radiol. 2016;26(11):4047–4056.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang ZB. High-intensity focused ultrasound tumor ablation: review of ten years of clinical experience. Front Med China. 2010;4(3):294–302.
   PubMedGoogle Scholar
• Sung HY, Jung SE, Cho SH, et al. Long-term outcome of high-intensity focused ultrasound in advanced pancreatic cancer. Pancreas. 2011;40(7):1080–1086.
   PubMed Web of Science ®Google Scholar
• Xiong LL, Hwang JH, Huang XB, et al. Early clinical experience using high intensity focused ultrasound for palliation of inoperable pancreatic cancer. JOP. 2009;10(2):123–129.
   PubMedGoogle Scholar
• Strunk HM, Henseler J, Rauch M, et al. Clinical Use of High-Intensity Focused Ultrasound (HIFU) for Tumor and Pain Reduction in Advanced Pancreatic Cancer. Rofo. 2016;188(7):662–670.
   PubMedGoogle Scholar
• Cranston D. A review of high intensity focused ultrasound in relation to the treatment of renal tumours and other malignancies. Ultrason Sonochem. 2015;27:654–658.
   PubMed Web of Science ®Google Scholar
• Wang K, Chen Z, Meng Z, et al. Analgesic effect of high intensity focused ultrasound therapy for unresectable pancreatic cancer. Int J Hyperthermia. 2011;27(2):101–107.
   PubMed Web of Science ®Google Scholar
• Marinova M, Huxold HC, Henseler J, et al. Clinical Effectiveness and Potential Survival Benefit of US-Guided High-Intensity Focused Ultrasound Therapy in Patients with Advanced-Stage Pancreatic Cancer. Ultraschall Med. 2019;40(5):625–637.
   PubMed Web of Science ®Google Scholar
• ter Haar G. Ultrasound focal beam surgery. Ultrasound Med Biol. 1995;21(9):1089–1100.
   PubMed Web of Science ®Google Scholar
• Shu-Qun Zx-D C, Zhao-You T. Histological changes in rabbit liver tumor after treatment with high intensity focused ultrasound. Chinese Jounal of Experimental Surgery. 1996;13:135–136.
   Google Scholar
• Li JJ, Xu GL, Gu MF, et al. Complications of high intensity focused ultrasound in patients with recurrent and metastatic abdominal tumors. World J Gastroenterol. 2007;13(19):2747–2751.
   PubMed Web of Science ®Google Scholar
• Shi Y, Ying X, Hu X, et al. Pain management of pancreatic cancer patients with high-intensity focused ultrasound therapy. Pakistan Journal of Pharmaceutical Sciences. 2017;30(1 Suppl):303–307.
   PubMed Web of Science ®Google Scholar
• Shi Y, Ying X, Hu X, et al. Influence of high intensity focused ultrasound (HIFU) treatment to the pancreatic function in pancreatic cancer patients. Pak J Pharm Sci. 2015;28(3 Suppl.):1097–1100.
   PubMed Web of Science ®Google Scholar